Page last updated: 2024-08-23

androstane-3,17-diol and Prostatic Diseases

androstane-3,17-diol has been researched along with Prostatic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauman, DR; Peehl, DM; Penning, TM; Steckelbroeck, S; Williams, MV1
Alroy, J; Merk, FB; Orgad, U; Ucci, A1

Reviews

1 review(s) available for androstane-3,17-diol and Prostatic Diseases

ArticleYear
Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.
    Laboratory investigation; a journal of technical methods and pathology, 1984, Volume: 50, Issue:3

    Topics: Androstane-3,17-diol; Animals; Binding, Competitive; Carbohydrates; Castration; Cell Differentiation; Dihydrotestosterone; Dog Diseases; Dogs; Epithelium; Estradiol; Histocytochemistry; Male; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Mitogen

1984

Other Studies

1 other study(ies) available for androstane-3,17-diol and Prostatic Diseases

ArticleYear
Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
    Molecular endocrinology (Baltimore, Md.), 2006, Volume: 20, Issue:2

    Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); Androgens; Androstane-3,17-diol; Animals; Cells, Cultured; Dihydrotestosterone; Fatty Acid Synthases; Humans; Male; NADH, NADPH Oxidoreductases; Prostate; Prostatic Diseases; Receptors, Androgen; Transcriptional Activation; Transfection

2006